High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody
AssigneeSpring BioScience Corporation
InventorsHaiying Xia, Zhida Huang
Life of this patent
Estimating the term…
Loading patent…
AssigneeSpring BioScience Corporation
InventorsHaiying Xia, Zhida Huang
Estimating the term…
High affinity monoclonal antibodies for recognizing estrogen receptor (clone SP1) with immunohistochemistry and methods for creating such an antibody are disclosed. The lagomorph derived ER antibody provides a significant advantage over the currently available mouse ER antibodies in that there is no need for target retrieval when performing immunohistochemistry. Furthermore, the very low background when the lagomorph derived ER antibody is used in immunohistochemistry is also impressive. The immunohistochemistry comparative study with about fifty clinical specimens showed that the new ER (clone SP1) antibody had favorable results when compared to mouse monoclonal ER antibodies (clone 1D5). The lagomorph derived ER antibody may prove of great value in the assessment of ER status in human breast cancer. Humanized versions of the ER antibody may also provide therapeutic benefits.
A rabbit monoclonal antibody having a specific affinity for human estrogen receptor that is higher than that of murine monoclonal antibody 1D5, wherein the rabbit monoclonal antibody specifically binds an epitope within amino acids 578–595 of the estrogen receptor alpha protein present in a fresh tissue section and present, in the absence of a tissue section processing step involving proteolytic digestion or heat treatment for antigen retrieval, in a formalin-fixed, paraffin-embedded tissue section after processing steps of deparaffinization and rehydration.
A method for selecting a monoclonal antibody for immunohistochemistry analysis of a human estrogen receptor, said method comprising the steps of:
Dependencies are inferred from the claim text.